Clinical Trials
Mayo Clinic Researcher to Present Findings on Aditxt's ADI-100™ Preclinical Study
Aditxt Inc. will host a May 2 update featuring Mayo Clinic's Dr. Charles Howe discussing key findings from a preclinical study of ADI-100™, offering insights into the company's immune modulation therapy research.
Calidi Biotherapeutics Receives FDA Clearance for Innovative Cancer Treatment Trial
Biotech firm Calidi Biotherapeutics has obtained FDA approval to begin clinical trials of CLD-201, a novel stem cell-based virotherapy targeting solid tumors. The therapeutic approach combines adipose-derived stem cells with oncolytic vaccinia virus, potentially offering a breakthrough in treating challenging cancer types.
DoD Awards $876,000 Grant to Advance Lung Cancer Biomarker Research at Cedars-Sinai
The U.S. Department of Defense has provided funding to Cedars-Sinai Medical Center to support biomarker research for Kairos Pharma's experimental lung cancer treatment, focusing on identifying potential early intervention strategies for patients developing resistance to current therapies.
Global Vision Study Launches Using App-Based Eye Exercise Program
A new study using the SniperSight app aims to validate century-old eye exercise techniques as a potential solution for the growing global vision crisis, with projections showing over 4 billion people will need vision correction by 2050.
Neutra Corp Expands into Clinical Research with New Site Management Program
Healthcare company Neutra Corp launches a technology-driven Site Management Organization pilot program to improve clinical trial efficiency and patient outcomes, marking a significant shift in how clinical research sites are managed and supported.
Common Migraine Drug Shows Promise in Reducing Stroke Risk for Women
New research reveals propranolol, a widely-used medication for migraines and high blood pressure, may significantly reduce ischemic stroke risk in women with migraines, particularly those without aura, highlighting an important advancement in women's cardiovascular health management.
High-Intensity Walking Program Shows Promising Results in Early Stroke Recovery
A new study demonstrates that incorporating 30 minutes of progressive walking exercise into standard stroke rehabilitation significantly improves patient mobility and quality of life, potentially reshaping stroke recovery protocols across rehabilitation facilities.